Sanjana Sathrasala

Sanjana Sathrasala

Auto-generated profile, based on publicly available information

Sanjana Sathrasala

Harvard Medical School, Boston, Massachusetts, USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 April 2020 in Ophthalmology Retina
Verified
Journal Article
Closed access
OMOmar Moinuddin
Omar Moinuddin
SSSanjana Sathrasala
Sanjana Sathrasala
KJK. Thiran Jayasundera
K. Thiran Jayasundera
KBKari H. Branham
Kari H. Branham
ECEmmanuel Y. Chang
Emmanuel Y. Chang
CBCagri G Besirli
Cagri G Besirli

1 August 2021 in Neurology Clinical Practice
Verified
Journal Article
Open access
PDF file
OMOmar Moinuddin
Omar Moinuddin
NKNikhila S. Khandwala
Nikhila S. Khandwala
KYKelly Z. Young
Kelly Z. Young
SSSanjana K. Sathrasala
Sanjana K. Sathrasala
SBSami J. Barmada
Sami J. Barmada
CBCagri G Besirli
Cagri G Besirli
Purpose of Review Frontotemporal dementia (FTD) is often misdiagnosed or recognized late. Clinical heterogeneity and overlap with other dementias impede accurate diagnosis. FTD biomarkers are limited, expensive, and invasive. We present a narrative review of the current literature focused on optical coherence tomography (OCT) to identify retinal biomarkers of dementia, discuss OCT findings in FTD, and explore the implications of an FTD-specific ocular biomarker for research and patient care. Recent Findings Recent studies suggest that outer retinal thinning detected via OCT may function as a novel ocular biomarker of FTD. The degree and rate of inner retinal thinning may correlate with disease severity and progression. In Alzheimer disease (AD), OCT demonstrates thinning of the inner retina, which may differentiate this condition from FTD. We conducted a comprehensive search of the literature and reviewed published OCT findings in FTD, AD, and mild cognitive impairment, as well as reports on biomarkers of FTD and AD used in the research and patient care settings. Three of the authors (O.M., N.S.K., and K.Z.Y.) independently conducted literature searches using PubMed to identify studies published before May 1, 2020, using the following search terminology: “Alzheimer9s disease,” “Alzheimer9s dementia,” “frontotemporal dementia,” “FTD,” “mild cognitive impairment,” “dementia biomarkers,” and “neurodegeneration biomarkers.” Search results were then refined using one or more of the following keywords: “optical coherence tomography,” “optical coherence tomography angiography,” “retinal imaging,” and “retinal thinning.” The selection of published works for inclusion in this narrative review was then limited to full-text articles written in English based on consensus agreement of the authors. Summary FTD diagnosis is imprecise, emphasizing the need for improved state and trait biomarkers. OCT imaging of the retina holds considerable potential for establishing effective ocular biomarkers for FTD.

26 February 2026 in BMJ Case Reports
Verified
Journal Article
Closed access
PDF file
SCSydney Corey
Sydney Corey
SSSanjana Sathrasala
Sanjana Sathrasala
SBSm Burnett-Bowie
Sm Burnett-Bowie
LGLaura R Glick
Laura R Glick
Phosphaturic mesenchymal tumours (PMTs) are rare benign tumours that secrete fibroblast growth factor 23 (FGF23), leading to phosphate wasting, disordered vitamin D metabolism and impaired bone mineralisation, clinically known as tumour-induced osteomalacia. PMTs are frequently misdiagnosed due to rarity and non-specific presentation. We report a case of a male in his 60s who presented to the hospital with 7 years of progressive muscle weakness and diffuse pain, resulting in inability to walk. His work-up was significant for hypophosphataemia with imaging showing chronic bilateral femoral neck fractures and 11 posterior rib fractures. Copper-64 DOTA-Phe 1 -Tyr 3 -Thr 8 -octreotate positron emission tomography/CT demonstrated increased uptake within the left femur. Venous sampling revealed elevated FGF23. He underwent resection of the femoral tumour with histology consistent with PMT. Within 1 year of resection, the patient showed significant improvement. This case highlights the diagnostic challenge of PMTs and the dramatic improvement that can occur following resection.